Style | Citing Format |
---|---|
MLA | Kanannejad Z, et al.. "Diagnosis and Selection of Alternative Antibiotics in Beta-Lactams Hypersensitivity Reactions: Current Recommendations and Challenges." International Immunopharmacology, vol. 122, no. , 2023, pp. -. |
APA | Kanannejad Z, Pourvali A, Esmaeilzadeh H, Shokouhi Shoormasti R, Reza Fazlollahi M, Fallahpour M, Zaremehrjardi F (2023). Diagnosis and Selection of Alternative Antibiotics in Beta-Lactams Hypersensitivity Reactions: Current Recommendations and Challenges. International Immunopharmacology, 122(), -. |
Chicago | Kanannejad Z, Pourvali A, Esmaeilzadeh H, Shokouhi Shoormasti R, Reza Fazlollahi M, Fallahpour M, Zaremehrjardi F. "Diagnosis and Selection of Alternative Antibiotics in Beta-Lactams Hypersensitivity Reactions: Current Recommendations and Challenges." International Immunopharmacology 122, no. (2023): -. |
Harvard | Kanannejad Z et al. (2023) 'Diagnosis and Selection of Alternative Antibiotics in Beta-Lactams Hypersensitivity Reactions: Current Recommendations and Challenges', International Immunopharmacology, 122(), pp. -. |
Vancouver | Kanannejad Z, Pourvali A, Esmaeilzadeh H, Shokouhi Shoormasti R, Reza Fazlollahi M, Fallahpour M, et al.. Diagnosis and Selection of Alternative Antibiotics in Beta-Lactams Hypersensitivity Reactions: Current Recommendations and Challenges. International Immunopharmacology. 2023;122():-. |
BibTex | @article{ author = {Kanannejad Z and Pourvali A and Esmaeilzadeh H and Shokouhi Shoormasti R and Reza Fazlollahi M and Fallahpour M and Zaremehrjardi F}, title = {Diagnosis and Selection of Alternative Antibiotics in Beta-Lactams Hypersensitivity Reactions: Current Recommendations and Challenges}, journal = {International Immunopharmacology}, volume = {122}, number = {}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Kanannejad Z AU - Pourvali A AU - Esmaeilzadeh H AU - Shokouhi Shoormasti R AU - Reza Fazlollahi M AU - Fallahpour M AU - Zaremehrjardi F TI - Diagnosis and Selection of Alternative Antibiotics in Beta-Lactams Hypersensitivity Reactions: Current Recommendations and Challenges JO - International Immunopharmacology VL - 122 IS - SP - EP - PY - 2023 ER - |